Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Thompson

Showing results (11-20 of 290) with videos related to

Pageof 29
Sort By:
Journal of Neurophysiology|October 4, 2013
Activity in mouse pedunculopontine tegmental nucleus reflects action and outcome in a decision-making taskJohn A Thompson, Gidon Felsen
Journal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
Systemic therapy for metastatic melanoma in 2012: dawn of a new eraShailender Bhatia, John A Thompson
Lancet (London, England)|July 19, 2014
Melanoma: immune checkpoint blockade story gets betterShailender Bhatia, John A Thompson
Clinical Toxicology (Philadelphia, Pa.)|August 12, 2025
Methotrexate-induced epidermal necrosisChristopher Kennedy, John A Thompson
JAMA|April 20, 2016
PD-1 Blockade in Melanoma: A Promising Start, but a Long Way to GoShailender Bhatia, John A Thompson
Journal of Neurophysiology|December 24, 2010
Endocannabinoids mediate synaptic plasticity at glutamatergic synapses on spiny neurons within a basal ganglia nucleus necessary for song learningJohn A Thompson, David J Perkel
Chemical Senses|January 15, 2016
MSG-Evoked c-Fos Activity in the Nucleus of the Solitary Tract Is Dependent upon Fluid Delivery and Stimulation ParametersJennifer M Stratford, John A Thompson
Expert Opinion on Biological Therapy|November 8, 2008
Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancerScott S Tykodi, John A Thompson
Plos One|September 6, 2014
Beta-galactosidase staining in the nucleus of the solitary tract of Fos-Tau-LacZ mice is unaffected by monosodium glutamate taste stimulationJennifer M Stratford, John A Thompson
The Lancet. Oncology|March 8, 2017
A second chance for success with BRAF and MEK inhibitors in melanomaKelly G Paulson, John A Thompson
Pageof 29

Showing results (11-20 of 290) with videos related to

Sort By:
Pageof 29
Journal of Neurophysiology|October 4, 2013
Activity in mouse pedunculopontine tegmental nucleus reflects action and outcome in a decision-making taskJohn A Thompson, Gidon Felsen
Journal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
Systemic therapy for metastatic melanoma in 2012: dawn of a new eraShailender Bhatia, John A Thompson
Lancet (London, England)|July 19, 2014
Melanoma: immune checkpoint blockade story gets betterShailender Bhatia, John A Thompson
Clinical Toxicology (Philadelphia, Pa.)|August 12, 2025
Methotrexate-induced epidermal necrosisChristopher Kennedy, John A Thompson
JAMA|April 20, 2016
PD-1 Blockade in Melanoma: A Promising Start, but a Long Way to GoShailender Bhatia, John A Thompson
Journal of Neurophysiology|December 24, 2010
Endocannabinoids mediate synaptic plasticity at glutamatergic synapses on spiny neurons within a basal ganglia nucleus necessary for song learningJohn A Thompson, David J Perkel
Chemical Senses|January 15, 2016
MSG-Evoked c-Fos Activity in the Nucleus of the Solitary Tract Is Dependent upon Fluid Delivery and Stimulation ParametersJennifer M Stratford, John A Thompson
Expert Opinion on Biological Therapy|November 8, 2008
Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancerScott S Tykodi, John A Thompson
Plos One|September 6, 2014
Beta-galactosidase staining in the nucleus of the solitary tract of Fos-Tau-LacZ mice is unaffected by monosodium glutamate taste stimulationJennifer M Stratford, John A Thompson
The Lancet. Oncology|March 8, 2017
A second chance for success with BRAF and MEK inhibitors in melanomaKelly G Paulson, John A Thompson
Pageof 29